Ligand validation:6PR2

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 6PR2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6PR2_SAH_A_603	87%	31%	0.082	0.953	1.2	1.52	3	4	0	0	100%	1
6PR2_SAH_B_603	86%	33%	0.096	0.964	1.25	1.42	2	2	0	0	100%	1
6VEB_SAH_A_501	96%	26%	0.059	0.966	1.35	1.66	2	3	0	0	100%	1
1PJS_SAH_B_503	95%	24%	0.057	0.959	1.56	1.55	1	1	0	0	100%	1
6P5Z_SAH_A_501	93%	29%	0.06	0.956	1.26	1.58	2	1	0	0	100%	1
6PR3_SAH_A_602	91%	29%	0.082	0.969	1.2	1.64	3	4	0	0	100%	1
6PR4_SAH_A_501	91%	31%	0.088	0.973	1.11	1.6	2	3	0	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
4KRG_SAH_A_502	100%	25%	0.018	0.997	1.3	1.74	3	5	2	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.